The global in-vitro diagnostics (IVD) market was valued at $44 billion in 2011
and is expected to have a modest growth during the study period. The U.S.
represented the biggest market for IVD equipments accounting for about a half
of the total market. The report studies various segments of the IVD market
including Clinical Chemistry, Molecular diagnostics, Immunoassays, Hematology
and Microbiology. Clinical chemistry dominates the global IVD market whereas
molecular diagnostics is expected to register the highest growth during the
study period. Increased patient awareness, patient self testing, rapidly aging
population globally and automated testing due to technical advances are the
major growth drivers of this market. Key players in the IVD market include
Roche Diagnostics, Abbott Diagnostics, Beckman Coulter, BD Diagnostics, and
Siemens Diagnostics.
Table of Contents
1. Introduction
1.1. Key Take-Away
1.2. Report Description
1.3. Markets Covered
1.4. Stake Holders
1.5. Research Methodology
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Winning Imperatives
3.4. Burning Issues
3.5. Value Chain Analysis
3.6. Price Trend Analysis
3.7. Market Dynamics
3.7.1. Driver Analysis
3.7.1.1. New & Improved Technologies
3.7.1.2. Large Application Area
3.7.1.3. Financial support from Governments
3.7.1.4. Medical Insurance Coverage
3.7.2. Restrains
3.7.2.1. Regulatory hurdles in different countries
3.7.2.2. Uneven distribution of healthcare services
3.7.3. Opportunities
3.7.3.1. Rising of Global Market
3.7.3.2. Participation of Small Companies
3.7.3.3. Positive Growth by M&A
3.8. Resent Trends
3.9. Regulatory Issues
3.10. Market Share Analysis
4. Immunoassays
4.1. Overview
4.2. Market Segmentation
4.2.1. Infectious Diseases
4.2.2. Cancer
4.2.3. Cardiac
4.2.4. Endocrine
4.2.5. Blood Screening
4.2.6. Other
4.3. Market Dynamics
5. Hematology
5.1. Overview
5.2. Market Segmentation
5.2.1. High Throughput Analyzer
5.2.2. Medium Throughput Analyzer
5.2.3. Low Throughput Analyzer
5.3. Market Dynamics
5.3.1. Automation in Laboratories
5.3.2. Point-of-Care and Development of Support Technologies
